Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation

Holly Anderton1, James A Rickard1, George A Varigos2

  • 1The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.

Insights

Inhibitor of apoptosis proteins (IAPs) are crucial for skin health. Genetic deletion or antagonism of IAPs in mice causes lethal skin inflammation, highlighting their importance in preventing cell death and maintaining skin homeostasis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Dermatology

Background:

  • Inhibitor of apoptosis proteins (IAPs) regulate cell death and survival.
  • The role of IAPs in skin homeostasis and inflammation is largely unknown.
  • Previous studies show IAP deficiency causes embryonic lethality or sterile inflammation in other tissues.

Purpose of the Study:

  • To investigate the role of IAPs in epidermal homeostasis and skin inflammation.
  • To determine the consequences of IAP deficiency in keratinocytes.
  • To explore therapeutic targets for skin inflammation.

Main Methods:

  • Generated epidermal-specific IAP-deficient mice (cIAP1 EKO).
  • Utilized combined genetic deletion of cIAP1 and cIAP2.
  • Administered IAP antagonist compound to wild-type and knockout mice.
  • Investigated the role of Ripk1 and LUBAC signaling pathways.

Main Results:

  • Combined deletion of cIAP1 and cIAP2 in epidermis caused lethal skin inflammation and keratinocyte death.
  • IAP antagonism induced toxic epidermal necrolysis-like inflammation.
  • Loss of one Ripk1 allele ameliorated inflammation and extended lifespan.
  • Ripk1 heterozygosity protected against dermatitis in Sharpin-deficient mice.

Conclusions:

  • cIAP1 and cIAP2 are essential for preventing skin inflammation and keratinocyte death.
  • IAP antagonism can trigger severe skin inflammation.
  • Ripk1 and LUBAC signaling pathways are critical in IAP-mediated skin homeostasis and inflammation.
  • These findings identify potential therapeutic targets for treating skin inflammatory diseases.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K